Biobank Cardiac Surgery

Part of paid clinical trials in Hyde Park, Illinois.

Sponsor
University of Chicago
Study ID
NCT06747806
Status
Recruiting
Apply to this trial

Conditions

  • Cardiovascular Diseases

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cardiac Surgery and Procedures — PROCEDURE
    To assess blood and tissue biomarkers of patients undergoing cardiac surgery

Study Details

Treatment strategies for cardiac surgery patients have been evolving significantly for the last decade. While clinical outcomes have been improving, there are still significant areas unexplored in these patients. Cardiac surgery, or cardiovascular surgery, is surgery on the heart or great vessels performed by cardiac surgeons. It is often used to treat complications of ischemic heart disease (for example, with coronary artery bypass grafting); to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditis, rheumatic heart disease, and atherosclerosis. Biobanking is a fundamental process required in the better understanding of human diseases together with their underlying mechanisms. Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve the understanding of health and disease. For this study, the investigator's objective is to acquire elucidation in disease etiology, translation, and advancing public health by evaluating blood and tissue results of those with cardiac disease undergoing cardiac surgery.

Key Dates

Start date
Dec 18, 2023
Status verified
Dec 2025
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Patients who undergo cardiac surgery and procedures
    Patients who undergo cardiac surgery and procedures will have tissue specimens that are removed during surgery and collected blood samples of 5 mL.

Primary Outcome Measure

Concentration of the elucidation in disease etiology from evaluating blood and tissue results [ Time Frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of ChicagoHyde ParkIllinois60637
Valluvan Jeevanandam, MD
Leila Yazdanbakhsh
[email protected]
7738345087
Valluvan Jeevanandam (PRINCIPAL_INVESTIGATOR)

Find similar trials in Hyde Park, IL

By research site
The University of Chicago· Hyde Park, IL

Related Studies